Target intelligence / Profile preview

C2CD4D and THEM5 antisense RNA 1 (C2CD4D-AS1)

Target
C2CD4D-AS1
Molecular classification
Long non-coding RNA, Antisense RNA, Other
01

Overview

C2CD4D and THEM5 antisense RNA 1 (C2CD4D-AS1) is a long non-coding RNA overexpressed in several human cancers, most notably lung adenocarcinoma. Functionally, it is involved in promoting cell proliferation, migration, and invasion, while suppressing apoptosis. Mechanistically, C2CD4D-AS1 acts as a competing endogenous RNA (ceRNA) for miR-3681-3p, leading to increased expression of the oncogenic kinase NEK2. Its transcription is directly upregulated by the transcription factor ETV4. C2CD4D-AS1 plays an important role in the malignant behavior of cancer cells and is under study both as a candidate biomarker and as a potential target for cancer therapy.

02

Mechanism of action

Not classically druggable; biological mechanism involves:\n- Acting as an RNA molecular sponge for microRNA miR-3681-3p, thereby upregulating NEK2 expression\n- Transcriptional activation via ETS variant transcription factor 4 (ETV4)

03

Biological functions

Regulation of gene expression (acting as a competing endogenous RNA/ceRNA, sponging miR-3681-3p)Promotion of cell proliferation, migration, and invasion in LUADInhibition of apoptosisModulation of ETV4 transcription factor activity
04

Disease associations

Cancer (notably lung adenocarcinoma/LUAD)Potentially other cancers with C2CD4D-AS1 overexpression (e.g., cervical squamous cell carcinoma, thymoma)
05

Safety considerations

No direct safety concerns are reported regarding therapeutic modulation of C2CD4D-AS1, but as a novel target, comprehensive safety data are lacking
06

Biomarkers

C2CD4D-AS1 is proposed as a biomarker for LUAD prognosis and as a potential molecular marker of malignant behavior

Beyond the preview

Go deeper on C2CD4D and THEM5 antisense RNA 1 (C2CD4D-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C2CD4D and THEM5 antisense RNA 1 (C2CD4D-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call